Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer.

A critical role is revealed for MMGT1 in shaping the TNBC immune microenvironment and targeting MMGT1 represents a promising strategy to improve anti-PD-1 immunotherapy outcomes, suggesting that targeting MMGT1 represents a promising strategy to improve anti-PD-1 immunotherapy outcomes.

Shao-Qing Liu, Hong-Bing Liu, Meng-Ying Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.